Kangxianhuanji Granules in the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis: a Randomized, Controlled Exploratory Clinical Study

The First Affiliated Hospital of Henan University of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•(1) A confirmed diagnosis of AE-IPF;
•(2) Aged between 40 and 80 years;
•(3) Without participations in other interventional trials in the previous one month;
•(4) With the informed consent signed.

•(1) Pregnant and lactating women;
•(2) Dementia, mental disorders and reluctant partners;
•(3) Complicated with heart failure (NYHA Class IV), or unstable hemodynamics, or hypertension (Grade-4), or serious cardiac arrhythmias (e.g., ventricular tachycardia, paroxysmal supraventricular tachycardia, ventricular flutter and ventricular fibrillation);
•(4) Complicated with Other diseases (e.g., bronchiectasis, active tuberculosis, pneumothorax, Pleural effusion, pulmonary thromboembolic, or Neuromuscular diseases affect respiratory movement function);
•(5) Treated outside the hospital for more than 7 days;
•(6) Need to carry out invasive mechanical ventilation respiratory failure;
•(7) Complicated with serious hepatic and renal diseases (liver cirrhosis, portal hypertension, bleeding of varicose veins, dialysis, or renal transplantation);
•(8) Bedridden for various reasons;
•(9) Allergic to the used medicine.

发起方

The First Affiliated Hospital of Henan University of Chinese Medicine